FDA Adverse Event Injury Summary report: N

ASR ACETABULAR CUPS 50

MDR report key: 2932595 · Received January 29, 2013

Report

Report Number
1818910-2013-01619
Event Type
Injury
Date Received
January 29, 2013
Report Date
August 29, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
K040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS COMPLAINT CLOSED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. (B)(4).

Description of Event or Problem · 1

**UPDATE** - MEDICAL RECORDS RECEIVED (B)(4) 2013. REVISION OPERATIVE REPORT INDICATES THE FOLLOWING: SIGNIFICANT METALLOSIS AS WELL AS BURSITIS WITH FLUID AS WELL AS NECROTIC AND PSEUDOTUMOR TYPE THICK BURSITIS TISSUE INVADING THE BURSAL REGION; SIGNIFICANT AMOUNTS OF CLEAR, SLIGHTLY METALLOSIS-TINGED FLUID WAS FOUND; SIGNIFICANT AMOUNTS OF PSEUDOTUMOR SYNOVITIS; METALLOSIS AND NECROTIC TISSUE THROUGHOUT THE AREA OF THE HIP, THE POSTERIOR CAPSULE AND ALL QUADRANTS OF THE ACETABULUM. THE INFORMATION RECEIVED DOES NOT CHANGE THE MDR DECISION.

Description of Event or Problem · 1

LITIGATION PAPERS ALLEGE THE PATIENT EXPERIENCED DEBILITATING PAIN AND DISCOMFORT IN HIPS AND LEGS, THEREBY INTERFERING WITH THE PATIENTS ABILITY TO PERFORM ACTIVITIES OF DAILY LIVING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
39558 ASR ACETABULAR CUPS 50 ACETABULAR CUP HIP IMPLANT KWA DEPUY INTERNATIONAL 2987505

Patients

Seq Age Sex Outcome Treatment
1 Other